Publications

  1. From Pharmacogenomics to Improved Patient Outcomes: Angiotensin I-Converting Enzyme as an Example
  2. Is Angiotensin I-Converting Enzyme a “Master” Disease Gene?
  3. Is “Somatic” Angiotensin I-Converting Enzyme a Mechanosensor?
  4. Pathophysiologic Implications of Angiotensin I-Converting Enzyme as a Mechanosensor: Diabetes
  5. Why AT1R blockade makes sense for SARS
  6. The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
  7. Written evidence included in July 7, 2009 report on genomic medicine by the British House of Lords (view report)
  8. Are Blockbuster Drugs Still Possible in the Era of Personalized Medicine?
  9. A Modern-Day Tuskegee… and What’s Really Wrong with U.S. Health Care Today?
  10. Precision Medicine — Too Much Precision, Not Enough Medicine?